Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
0.7513
+0.0013 (0.17%)
At close: Sep 18, 2026, 4:00 PM EDT
0.7400
-0.0113 (-1.50%)
After-hours: Sep 18, 2026, 7:05 PM EDT

Akso Health Group Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Operating Revenue
6.8377.846.931.520.891.3211.86-0.06
Other Revenue
---------0.19
6.8377.846.931.520.891.3211.86-0.25
Revenue Growth (YoY)
-12.88%0.93%415.77%676.00%14.82%-92.46%-4721.44%--81.83%
Cost of Revenue
7.476.388.326.741.440.851.1810.73--
Gross Profit
-0.630.62-0.470.190.080.040.141.13-0.25
Selling, General & Admin
1.932.062.910.736.412.3514.191.35-7.72
Operating Expenses
1.932.062.910.736.412.3514.191.35-8.12
Operating Income
-2.56-1.44-3.38-0.54-6.32-2.32-14.05-0.22--7.87
Interest Expense
----------0.6
Currency Exchange Gain (Loss)
0-0-000.05-0.65-0.581.73--
Other Non Operating Income (Expenses)
-0-00.010.030.21-0.08-0.090.15--0.43
EBT Excluding Unusual Items
-2.56-1.44-3.37-0.51-6.05-3.04-14.731.66--8.9
Impairment of Goodwill
-11.07--41.37-------
Asset Writedown
-5.63--121.01-------
Pretax Income
-19.26-1.44-165.76-0.51-6.05-3.04-14.731.66--8.9
Income Tax Expense
-1.85-0.14-30.840.0400.020.010.01-0.02
Earnings From Continuing Operations
-17.42-1.3-134.92-0.55-6.05-3.06-14.731.65--8.92
Earnings From Discontinued Operations
-----0.01-0.3912.66-0.82--
Net Income to Company
-17.42-1.3-134.92-0.55-6.06-3.46-2.070.83--8.92
Minority Interest in Earnings
0.020.030.53-0.030.06-0-0.1-0.02--
Net Income
-17.4-1.28-134.39-0.59-6-3.46-2.170.81--8.92
Net Income to Common
-17.4-1.28-134.39-0.59-6-3.46-2.170.81--8.92
Net Income Growth (YoY)
----------
Shares Outstanding (Basic)
85658933723371232323-17
Shares Outstanding (Diluted)
85658933723371232323-17
Shares Change (YoY)
153.97%152.81%371.72%919.05%212.60%--35.37%-3.61%
EPS (Basic)
-0.02-0.00-0.40-0.00-0.08-0.15-0.090.04--0.53
EPS (Diluted)
-0.02-0.00-0.40-0.00-0.10-0.15-0.110.03--0.54
EPS Growth (YoY)
----------

Additional Metrics

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Free Cash Flow
161.64-174.436-4.981.110.24-1.92-1.33--9.33
Free Cash Flow Per Share
0.19-0.300.02-0.020.020.01-0.08-0.06--0.55
Operating Margin
-37.50%-20.54%-43.12%-7.80%-415.73%-259.16%-1060.54%-1.86%--3200.11%
Profit Margin
-254.58%-18.23%-1713.38%-8.46%-394.62%-386.94%-163.86%6.83%--3625.56%
Free Cash Flow Margin
2365.51%-2492.40%76.49%-71.77%72.92%27.12%-144.90%-11.25%--3792.01%
EBITDA
-1.42-0.21-1.25-0.52---14.04-0.21--7.87
D&A For EBITDA
1.151.222.130.02--00.010.010
EBIT
-2.56-1.44-3.38-0.54-6.32-2.32-14.05-0.22--7.87
Revenue as Reported
6.8377.846.931.520.891.3211.86-0.25
Advertising Expenses
-------0.1-0
SEC Filings: 10-K · 10-Q